Inicio › Cáncer de ovario › Virginia
Ensayos clínicos de Cáncer de ovario en Virginia
57 estudios sobre Cáncer de ovario buscan participantes en Virginia.
Ciudades en Virginia
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Ballad Health Cancer Care - Bristol, Bristol
- University of Virginia Cancer Center, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- y 5 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 2 oct 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Virginia Cancer Specialists, Fairfax
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Inova Schar Cancer Institute, Fairfax
- NEXT Virginia, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06270706A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Virginia, Charlottesville
- NEXT Virginia, Fairfax
ReclutandoFase 1
Edades de 19 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Next Virginia /ID# 279684, Fairfax
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2026 · NCT07024784A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- Next Virginia /ID# 278607, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07278336A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Site 04, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07814248First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- NEXT Virginia, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06799065A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0295 - Virginia Oncology Associates, Chesapeake
- Site 0322 - Inova Schar Cancer Institute, Fairfax
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT05128825A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- UVA Health University Hospital /ID# 275309, Charlottesville
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax
- Virginia Oncology Associates- Norfolk (Brock) /ID# 275227, Norfolk
- y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT06890338Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Virginia Commonwealth University/ Massey Cancer Center, Richmond
ReclutandoEstudio observacional
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT05051722Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05867251Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Virginia Commonwealth University, Richmond
ReclutandoFase 1/2
Edades de 18 en adelante · Mujeres · Actualizado el 25 sept 2026 · NCT03564340Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Virginia Cancer Specialists, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- NEXT Oncology, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07109726A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax
- Virginia Oncology Associates (VOA) ( Site 8013), Norfolk
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 17 sept 2026 · NCT07318558A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Virginia Cancer Specialists, Fairfax
- Carilion Clinic, Roanoke
ReclutandoFase 2
Edades de 18 a 99 · Mujeres · Actualizado el 15 sept 2026 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of Virginia Health System, Charlottesville
- Inova Schar Cancer Institute, Fairfax
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 15 sept 2026 · NCT07214779FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Inova Schar Cancer Institute, Fairfax
- Next Oncology Virginia, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT06303505Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Virginia Cancer Specialists, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06293898Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
- NEXT Oncology, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 3 sept 2026 · NCT07755436A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 3 sept 2026 · NCT06824467The Vanguard Study: Testing a New Way to Screen for Cancer
- Sentara Martha Jefferson Hospital, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
- y 5 más
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- University of Virginia, Charlottesville
ReclutandoFase 1
Edades de 15 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT06276491A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Inova Schar Cancer Institute, Falls Church
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06774963Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Fairfax
ReclutandoFase 1/2
Edades de 18 a 130 · Todos los sexos · Actualizado el 21 ago 2026 · NCT05797168A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07182149A Study of PHST001 in Advanced Solid Tumors
- NEXT Oncology - Virginia, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT06840886A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- University of Virginia Cancer Center, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
- y 5 más
Reclutando
Edades de 35 a 50 · Mujeres · Actualizado el 7 ago 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06580314A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT07749586Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07444814A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Virginia Cancer Specialists, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06330064Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Virginia Cancer Specialists, Fairfax
- USOR Virginia Oncology Associates, Norfolk
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2026 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Virginia Cancer Specialists, Fairfax
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jul 2026 · NCT04657068A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- University of Virginia Comprehensive Cancer Center, Charlottesville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 jul 2026 · NCT06161025Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- NEXT Virginia, Fairfax
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT07524322Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 522, Fairfax
- 300, Norfolk
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 16 jul 2026 · NCT06906341Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- University of Virginia, Richmond
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 14 jul 2026 · NCT04606914De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.